Clinical Trials Logo
  1. Home
  2. Voiding Dysfunction
  3. NCT01154946

Clinical Implication of DAC (Detrusor After-contraction) — DAC  

Voiding Dysfunction Clinical Trial

Official title:
A New Approach to Clinical Implication of Detrusor After-contraction (DAC)

Clinical Trial Summary

The aims of this study are

- to confirm whether detrusor after-contraction (DAC) is a true contraction or not with a new approach

- and to understand clinical implication of DAC

Clinical Trial Description

The definition of detrusor after-contraction (DAC) is usually accepted as the increase of detrusor pressure (Pdet), whether it is sudden or not, after cessation of urinary flow. The amount of increase in Pdet is sometimes included in the definition of DAC (14, 15, 20 cmH2O or at least two times the level of the maximal Pdet during the voiding phase). However, it is clear that the lack of a well-established definition may induce much bias in the interpretation of the clinical implication of DAC. The previous studies showed a wide range of prevalence.1-4 DAC seemed to occur more frequently in children and the occurrence rate usually decreased with age in urodynamic studies. ;

Study Design

Observational Model: Case Control, Time Perspective: Retrospective

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01154946
Study type Observational
Source Seoul National University Hospital
Contact
Status Completed
Phase N/A
Start date January 2007
Completion date December 2008
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT05439902 - Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women N/A
Terminated NCT00713908 - Voiding Dysfunction in the Postoperative Period Following Placement of the TVT N/A
Completed NCT00679315 - Efficacy and Safety of Alfuzosin for the Treatment of Voiding Dysfunction in Female Phase 2
Completed NCT04010591 - The Measurement of Bladder Impedance and Heart Rate During Urodynamic Study
Completed NCT00719589 - Outcomes of Pudendal InterStim N/A
Completed NCT01189136 - Treatment for Acute Postoperative Voiding Dysfunction N/A
Completed NCT00214045 - Rigid Versus Flexible Cystoscopy in Women N/A
Completed NCT05820139 - Evaluating the Optimal Volume Voided for Passage of a Backfill-Assisted Voiding Trial Following Urogynecologic Surgery N/A
Completed NCT03574610 - Brain Targets in Patients With Bladder Emptying Difficulties N/A
Recruiting NCT00839969 - Cystoscopy Plus Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding N/A
Completed NCT01197248 - Randomized Controlled Trial of Cystocele Plication Risks ("CPR Trial"): A Pilot Study Phase 2
Recruiting NCT03913819 - Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction
Withdrawn NCT02297178 - A Follow-net Investigation of a Randomised Study of Cystoscopy and Urethral Dilatation Versus Cystoscopy Alone in Women With Overactive Bladder Syndrome and Impaired Voiding N/A
Not yet recruiting NCT06404996 - Smart-phone Application Versus Conventional Paper for the Documentation of Voiding Dysfunction in Children N/A
Completed NCT05295823 - Patient Self Measurement of Post-Void Residual Bladder Volume (PVR) Using Ultrasound N/A
Active, not recruiting NCT02193451 - Urodynamics for Prostate Surgery Trial; Randomised Evaluation of Assessment Methods N/A
Completed NCT01228370 - Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder Phase 4